Vezitic

VEZITIC

Solifenacin

CCL Pharmaceuticals (Pvt.) Ltd.

Drug Identity

Active Ingredient
Solifenacin
Drug Class
General
0

How to Take It

Dosage information not available for this product.

Safety Alerts

Urinary retention, severe GI conditions, toxic megacolon, myasthenia gravis, narrow-angle glaucoma, haemodialysis, severe hepatic impairment

Important Warnings

Bladder outflow obstruction at risk of urinary retention, GI obstruction, risk of oesophagitis, reduced GI motility, severe renal or moderate hepatic impairment, autonomic neuropathy, hiatus hernia, oesophageal reflux, neurogenic bladder disorder, susceptibility to QT-interval prolongation

Side Effects

Gastro-oesophageal refluxoedemadysphoniahepatic impairmenthyperkalaemiamuscle weaknessreduced appetitetorsade de pointesdry mouthGI upsetblurred vision.

Drug Interactions

Inhibitors
inducers or substrates of CYP3A4
cholinergic agonists
anticholinergics
GI motility stimulants.

Pregnancy & Lactation

Pregnancy
Avoid, use only when potential benefit outweighs risk.
Lactation
Caution advised, avoid

Price Intelligence

Rs 480
Servaid observed price · as of 30 July 2026
No approved ceiling matched to this exact pack and strength.
Prices across sources
ServaidRs 480

Should you consider an alternative?

Other options containing Solifenacin, and what they are not.You pay Rs 130 more than the cheapest equivalent

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.